Undifferentiated pleomorphic sarcoma, inflammatory variant

MONDO:0006480

An undifferentiated pleomorphic sarcoma characterized by the presence of numerous inflammatory cells.

Also known as: inflammatory MFH, inflammatory malignant fibrous histiocytoma, malignant xanthogranuloma, undifferentiated pleomorphic sarcoma, inflammatory variant

2835 clinical trials for this condition and its sub-types, 2 tagged with Undifferentiated pleomorphic sarcoma, inflammatory variant itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Undifferentiated pleomorphic sarcoma (48)

Including sub-types (2835) Tagged with Undifferentiated pleomorphic sarcoma, inflammatory variant (2)

Trials to join now! 1 Not yet finished but already full! 1

New hope for rare sarcomas: chemo plus immunotherapy combo enters phase III trial

Disease control Recruiting now

This Phase III trial tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (doxorubicin) helps people with advanced dedifferentiated liposarcoma or undifferentiated pleomorphic sarcoma live longer without their cancer worsening. About 365 adults whose…

Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Sep 10, 2026 00:00 UTC

Undifferentiated pleomorphic sarcoma, inflammatory variant

Where it sits in the disease tree

New hope for rare sarcomas: chemo plus immunotherapy combo enters phase III trial